AK Medical Holdings Limited (HKG:1789)
6.27
+0.46 (7.92%)
At close: Mar 27, 2026
AK Medical Holdings Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 357.23 | 352.17 | 331.22 | 625.83 | 475.61 |
Short-Term Investments | 1,189 | 2.5 | 2.88 | 3.05 | 3.1 |
Trading Asset Securities | - | 615.24 | 395.46 | 416.59 | 365.53 |
Cash & Short-Term Investments | 1,547 | 969.91 | 729.55 | 1,045 | 844.23 |
Cash Growth | 59.46% | 32.95% | -30.22% | 23.84% | -6.64% |
Accounts Receivable | 694.16 | 576.68 | 530.18 | 545.35 | 530.45 |
Other Receivables | - | 54.9 | 58.06 | 7.35 | 12.87 |
Receivables | 694.16 | 631.58 | 588.24 | 552.71 | 543.32 |
Inventory | 459.22 | 488.67 | 595.51 | 402.33 | 423.07 |
Other Current Assets | - | 87.9 | 61.52 | 64.85 | 123.75 |
Total Current Assets | 2,700 | 2,178 | 1,975 | 2,065 | 1,934 |
Property, Plant & Equipment | 699.74 | 683.62 | 574.97 | 435.63 | 382.4 |
Goodwill | 113.41 | 113.41 | 113.41 | 113.41 | 132.45 |
Other Intangible Assets | 81.13 | 83.34 | 87.97 | 85.28 | 79.99 |
Long-Term Deferred Tax Assets | 68.5 | 70.68 | 67.26 | 74.82 | 76.07 |
Other Long-Term Assets | - | 206.3 | 184.6 | - | - |
Total Assets | 3,663 | 3,335 | 3,003 | 2,774 | 2,605 |
Accounts Payable | 197.11 | 152.1 | 174.92 | 155.17 | 92.77 |
Accrued Expenses | 278.73 | 93.47 | 74.5 | 88.2 | 93.45 |
Current Portion of Long-Term Debt | 71.96 | 60.45 | 21.39 | - | - |
Current Portion of Leases | 4.99 | 12.12 | 14.24 | 13.5 | 10.95 |
Current Income Taxes Payable | 19.44 | 24.8 | 17.6 | 22.77 | 51.52 |
Current Unearned Revenue | 85.72 | 102.91 | 85.3 | 79.85 | 167.41 |
Other Current Liabilities | - | 150.58 | 110.22 | 76.9 | 73.33 |
Total Current Liabilities | 657.94 | 596.42 | 498.17 | 436.38 | 489.44 |
Long-Term Debt | 5.22 | 17.67 | 32.26 | - | - |
Long-Term Leases | 4.27 | 9.15 | 16.31 | 25.28 | 30.61 |
Long-Term Unearned Revenue | 18.89 | 19.64 | 10.43 | 13.33 | 12.35 |
Long-Term Deferred Tax Liabilities | 56.14 | 48.54 | 48.03 | 47.41 | 41.34 |
Other Long-Term Liabilities | 7.37 | 5.8 | 5.93 | 8.32 | - |
Total Liabilities | 749.83 | 697.21 | 611.12 | 530.73 | 573.73 |
Common Stock | 9.53 | 9.52 | 9.51 | 9.45 | 9.45 |
Additional Paid-In Capital | - | 966.52 | 960.98 | 1,009 | 1,032 |
Retained Earnings | - | 1,623 | 1,395 | 1,213 | 1,008 |
Comprehensive Income & Other | 2,903 | 39 | 26.19 | 12.55 | -18.46 |
Shareholders' Equity | 2,913 | 2,638 | 2,392 | 2,244 | 2,032 |
Total Liabilities & Equity | 3,663 | 3,335 | 3,003 | 2,774 | 2,605 |
Total Debt | 86.43 | 99.39 | 84.2 | 38.78 | 41.56 |
Net Cash (Debt) | 1,460 | 870.52 | 645.35 | 1,007 | 802.67 |
Net Cash Growth | 67.73% | 34.89% | -35.89% | 25.42% | -8.52% |
Net Cash Per Share | 1.30 | 0.78 | 0.58 | 0.90 | 0.72 |
Filing Date Shares Outstanding | 1,124 | 1,123 | 1,122 | 1,116 | 1,116 |
Total Common Shares Outstanding | 1,124 | 1,123 | 1,122 | 1,116 | 1,116 |
Working Capital | 2,042 | 1,582 | 1,477 | 1,629 | 1,445 |
Book Value Per Share | 2.59 | 2.35 | 2.13 | 2.01 | 1.82 |
Tangible Book Value | 2,718 | 2,441 | 2,191 | 2,045 | 1,819 |
Tangible Book Value Per Share | 2.42 | 2.17 | 1.95 | 1.83 | 1.63 |
Land | - | 72.72 | 72.72 | 72.72 | 21.41 |
Machinery | - | 432.54 | 434.91 | 353.99 | 308.62 |
Construction In Progress | - | 271.05 | 145.25 | 19.48 | 12.41 |
Leasehold Improvements | - | 87.38 | 88.85 | 82.52 | 77.93 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.